Susquehanna International Group, LLP Coh Bar, Inc. Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.17 - $0.34 $4,291 - $8,583	25,246 New	25,246 $5,000
Q3 2020 Nov 16, 2020	SELL	$0.87 - $2.08 $31,052 - $74,241	-35,693 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.08 - $4.0 $26,557 - $98,360	24,590 Added 221.47%	35,693 $55,000
Q1 2020 May 15, 2020	BUY	$1.01 - $2.74 $11,214 - $30,422	11,103 New	11,103 $13,000
Q1 2019 May 15, 2019	SELL	$2.95 - $4.16 $30,131 - $42,490	-10,214 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.97 - $4.52 $30,335 - $46,167	10,214 New	10,214 $32,000
Q2 2018 Aug 14, 2018	SELL	$4.44 - $10.4 $172,218 - $403,395	-38,788 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.85 - $6.92 $188,121 - $268,412	38,788 New	38,788 $202,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.28M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.